These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18774113)

  • 1. Proceedings of the ICD Lead Performance Conference.
    Maisel WH; Hauser RG
    Heart Rhythm; 2008 Sep; 5(9):1331-8. PubMed ID: 18774113
    [No Abstract]   [Full Text] [Related]  

  • 2. Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures.
    Hammill SC; Kremers MS; Stevenson LW; Kadish AH; Heidenreich PA; Lindsay BD; Mirro MJ; Radford MJ; Wang Y; Curtis JP; Lang CM; Harder JC; Brindis RG
    Heart Rhythm; 2008 Sep; 5(9):1359-63. PubMed ID: 18774117
    [No Abstract]   [Full Text] [Related]  

  • 3. An ICD lead advisory: a plea for more diligence and more data.
    Kay GN; Ellenbogen KA
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):648-9. PubMed ID: 22583068
    [No Abstract]   [Full Text] [Related]  

  • 4. The year in clinical electrophysiology.
    Scheinman MM; Keung E
    J Am Coll Cardiol; 2006 Mar; 47(6):1207-13. PubMed ID: 16545653
    [No Abstract]   [Full Text] [Related]  

  • 5. Living with an advisory ICD: how are the patients doing?--Actually just fine.
    Birnie DH; Keren A
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):1004-5. PubMed ID: 19659619
    [No Abstract]   [Full Text] [Related]  

  • 6. Troubleshooting implantable cardioverter-defibrillator related problems.
    van Erven L; Schalij MJ
    Heart; 2008 May; 94(5):649-60. PubMed ID: 18411360
    [No Abstract]   [Full Text] [Related]  

  • 7. An analysis of implantable cardiac device reliability. The case for improved postmarketing risk assessment and surveillance.
    Laskey W; Awad K; Lum J; Skodacek K; Zimmerman B; Selzman K; Zuckerman B
    Am J Ther; 2012 Jul; 19(4):248-54. PubMed ID: 22668602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter-defibrillator product reliability: recalling lessons from a tragic case.
    Estes NA
    Heart Rhythm; 2005 Jul; 2(7):684-6. PubMed ID: 15992720
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-Term Stability and Clinical Utility of Amplified Atrial Electrograms in a Single-Lead ICD System with Floating Atrial Electrodes.
    Worden NE; Alqasrawi M; Mazur A
    Pacing Clin Electrophysiol; 2016 Dec; 39(12):1327-1334. PubMed ID: 27778352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from the failure and recall of an implantable cardioverter-defibrillator.
    Hauser RG; Maron BJ
    Circulation; 2005 Sep; 112(13):2040-2. PubMed ID: 16172264
    [No Abstract]   [Full Text] [Related]  

  • 11. High quality performance of pacemakers and implantable defibrillators.
    Levine PA; Stanton MS; Sims JJ
    Pacing Clin Electrophysiol; 2002 Dec; 25(12):1667-9. PubMed ID: 12520665
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and Efficacy of the Subcutaneous Implantable Defibrillator.
    Lewis GF; Gold MR
    J Am Coll Cardiol; 2016 Feb; 67(4):445-454. PubMed ID: 26821634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recall actions for implantable defibrillators -- how do you counsel your defibrillator patients now?].
    Lüderitz B
    MMW Fortschr Med; 2005 Aug; 147(33-34):8-9. PubMed ID: 16138625
    [No Abstract]   [Full Text] [Related]  

  • 14. Deaths associated with implantable cardioverter defibrillator failure and deactivation reported in the United States Food and Drug Administration Manufacturer and User Facility Device Experience Database.
    Hauser RG; Kallinen L
    Heart Rhythm; 2004 Oct; 1(4):399-405. PubMed ID: 15851191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Here we go again--another failure of postmarketing device surveillance.
    Hauser RG
    N Engl J Med; 2012 Mar; 366(10):873-5. PubMed ID: 22332951
    [No Abstract]   [Full Text] [Related]  

  • 16. Implantable cardioverter-defibrillator lead failure: how weak is the link?
    Brinker JA
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of death in chronic kidney disease: the role of implantable cardioverter defibrillators.
    Turner S; Onalan O; Bickle B
    CANNT J; 2009; 19(3):29-36; quiz 37-8. PubMed ID: 19899497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods of ambulatory detection and treatment of cardiac arrhythmias using implantable cardioverter-defibrillators.
    Shrivastav M
    Biomed Instrum Technol; 1999; 33(6):505-21. PubMed ID: 10626042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter defibrillators: risks accompany the life-saving benefits.
    Atwater BD; Daubert JP
    Heart; 2012 May; 98(10):764-72. PubMed ID: 22422588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death should not restrict their use].
    Francia P; Cappato R
    G Ital Cardiol (Rome); 2011 May; 12(5):379-82; discussion 382. PubMed ID: 21593958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.